首页> 美国卫生研究院文献>Clinical and Diagnostic Laboratory Immunology >Specific HLA-DRB and -DQB Alleles and Haplotypes Confer Disease Susceptibility or Resistance in Bahraini Type 1 Diabetes Patients
【2h】

Specific HLA-DRB and -DQB Alleles and Haplotypes Confer Disease Susceptibility or Resistance in Bahraini Type 1 Diabetes Patients

机译:特定的HLA-DRB和-DQB等位基因和单倍型在巴林1型糖尿病患者中赋予疾病易感性或耐药性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Insofar as genetic susceptibility to type 1 diabetes is associated with HLA class II genes, with certain allelic combinations conferring disease susceptibility or resistance, this study assessed the distributions of HLA-DR and -DQ among 107 unrelated patients with type 1 diabetes and 88 healthy controls from Bahrain, all of Arab origin. The HLA-DRB and -DQB genotypes were determined by PCR-sequence-specific priming. The following alleles showed the strongest association with type 1 diabetes among patients versus controls according to their frequencies: DRB1*030101 (0.430 versus 0.097; P < 0.001), DRB1*040101 (0.243 versus 0.034; P < 0.001), DQB1*0201 (0.467 versus 0.193; P < 0.001), and DQB1*0302 (0.229 versus 0.091; P < 0.001). When the frequencies of alleles in controls were compared to those in patients, negative associations were seen for DRB1*100101 (0.085 versus 0.014; P < 0.001), DRB1*110101 (0.210 versus 0.060; P < 0.001), DQB1*030101 (0.170 versus 0.075; P = 0.006), and DQB1*050101 (0.335 versus 0.121; P < 0.001). In addition, the DRB1*030101-DQB1*0201 (70.1 versus 22.7%; P < 0.001) and DRB1*030101-DQB1*0302 (21.5 versus 0.0%; P < 0.001) genotypes were more prevalent among patients, thereby conferring disease susceptibility, whereas the DRB1*100101-DQB1*050101 (20.5 versus 2.8%; P < 0.001), DRB1*110101-DQB1*030101 (28.4 versus 8.4%; P < 0.001), and DRB1*110101-DQB1*050101 (30.7 versus 0.9%; P < 0.001) genotypes were more prevalent among controls, thus assigning a protective role. These results confirm the association of specific HLA-DR and -DQ alleles and haplotypes with type 1 diabetes and may underline several characteristics that distinguish Bahraini patients from other Caucasians patients.
机译:就1型糖尿病的遗传易感性与HLA II类基因相关联,并通过某些等位基因组合赋予疾病易感性或耐药性的情况,本研究评估了107名无关的1型糖尿病患者和88名健康对照者中HLA-DR和-DQ的分布来自巴林,全部来自阿拉伯。 HLA-DRB和-DQB基因型通过PCR序列特异性引物确定。以下等位基因显示与频率相对应的患者与对照组之间与1型糖尿病的最强关联:DRB1 * 030101(0.430 vs 0.097; P <0.001),DRB1 * 040101(0.243 vs 0.034; P <0.001),DQB1 * 0201( 0.467对0.193; P <0.001)和DQB1 * 0302(0.229对0.091; P <0.001)。当比较对照组中的等位基因频率与患者中的等位基因频率时,DRB1 * 100101呈负相关(0.085对0.014; P <0.001), DRB1 * 110101 ( 0.210对0.060; P <0.001), DQB1 * 030101 (0.170对0.075; P = 0.006),和 DQB1 * 050101 (0.335对0.121; P <0.001)。此外, DRB1 * 030101 - DQB1 * 0201 (70.1对22.7%; P < / em> <0.001)和 DRB1 * 030101 - DQB1 * 0302 (21.5对0.0%; P <0.001)基因型在患者中更为普遍,从而赋予疾病易感性,而 DRB1 * 100101 - DQB1 * 050101 (20.5对2.8%; P <0.001), DRB1 * 110101 - DQB1 * 030101 (28.4对8.4%; P <0.001)和 DRB1 * 110101 - DQB1 * 050101 (30.7对0.9%; P <0.001)基因型在对照组中更为普遍,因此具有保护作用。这些结果证实了特定的HLA-DR和-DQ等位基因及单倍型与1型糖尿病的关联,并可能强调了将巴林患者与其他高加索患者区分开的几个特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号